Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 3.

Journal Article

Ben Khaled, Najib, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Roessler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael ORCID: 0000-0002-4463-8263, Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom ORCID: 0000-0002-6288-8821, Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N. (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol. Future Oncol., 18 (12). S. 1423 - 1436. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

De Toni, Enrico N., Kubisch, Ilja, Ben Khaled, Najib, Ricke, Jens, Mayerle, Julia, Ehmer, Ursula, Waldschmidt, Dirk, Roessler, Daniel Christoph, Oehrle, Bettina, Bitzer, Michael, Kandulski, Arne, Reuken, Philipp A., Wege, Henning and Seidensticker, Max (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: The DEMAND randomized phase II clinical trial. J. Clin. Oncol., 40 (4). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Sinner, Friedrich ORCID: 0000-0003-0524-8833, Pinter, Matthias ORCID: 0000-0002-7260-532X, Scheiner, Bernhard ORCID: 0000-0002-4904-5133, Ettrich, Thomas Jens, Sturm, Niklas ORCID: 0000-0001-9219-0099, Gonzalez-Carmona, Maria A., Waidmann, Oliver, Finkelmeier, Fabian ORCID: 0000-0001-8559-9910, Himmelsbach, Vera, De Toni, Enrico N., Ben Khaled, Najib, Mohr, Raphael ORCID: 0000-0003-2403-4275, Fruendt, Thorben Wilhelm, Kuetting, Fabian, van Boemmel, Florian, Lieb, Sabine, Krug, Sebastian ORCID: 0000-0003-1672-7995, Bettinger, Dominik ORCID: 0000-0002-8782-8729, Schultheiss, Michael, Jochheim, Leonie S., Best, Jan, Mueller, Christian ORCID: 0000-0002-6881-1817, Keitel, Verena and Venerito, Marino ORCID: 0000-0001-8581-0974 (2022). Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers, 14 (23). BASEL: MDPI. ISSN 2072-6694

This list was generated on Sun Nov 24 04:22:17 2024 CET.